ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
INNATE PHARMA: cashflow_investing
One fact, its scope and the complete path back to the official record.
Reported value
-917.000k{"amount": -917000.0, "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities"}- Entity
- INNATE PHARMA
- Metric
- cashflow_investing
- Period
- 2021-01-01 – 2021-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:9695002Y8420ZB8HJE29:2022-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-24T01:03:17.534690+02:00
Raw response SHA-256
53d82a9d3a67280755c68bee6873bd4d…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.